Monoclonals Inc. makes novel monoclonal antibodies for use in the diagnosis of viral diseases. Monoclonal antibodies enable the development of rapid test kits that allow physicians to quickly diagnose these diseases. Such diagnostic tools are extremely important in the treatment of infectious diseases.

Often described as a “magic bullet,” monoclonal antibodies selectively target disease-causing organisms. The antibodies are used to diagnose the presence of disease-causing organisms, as in rapid test kits, or as vehicles to deliver targeted therapeutics such as drugs, toxins or radioactive isotopes. They are especially important in the treatment of infectious diseases and cancer.



To learn more about what Monoclonals, Inc. is working on, contact Christine Soto at